Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Current treatments for alopecia show no significant long-term benefits.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Deformable vesicular carriers improve drug delivery for skin conditions and systemic treatments.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

A cat with skin bumps and itching had high blood fats and skin infections, which improved with diet and medication changes.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Pertussis toxin may contribute to hair loss in alopecia areata.

Electrospun nanofibers might be a promising new treatment for hair loss.

A scalp biopsy is essential for accurately identifying different types of hair loss.